Divi’s Labs hits 52-week high as street cheers record Q2; Elara at ‘Sell’
The Hindu BusinessLine

Divi's Laboratories shares hit a 52-week high following strong second-quarter financial results.
Divi's Laboratories stock opened flat at ₹11,097 before gaining momentum as the market responded to the company's record second-quarter performance. Despite the positive market reaction and new 52-week high, brokerage firm Elara maintained a sell rating on the stock. The quarterly results were announced on a Saturday, with trading activity picking up once the market processed the financial data.
Why it matters: The contrasting market enthusiasm and bearish analyst rating highlight divergent views on the valuation of a major pharmaceutical firm following strong quarterly earnings.






